Toll Free: 1-888-928-9744

Scabies Global Clinical Trials Review, H1, 2016

Published: May 31, 2016 | Pages: 43 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Scabies Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Scabies Global Clinical Trials Review, H1, 2016" provides an overview of Scabies clinical trials scenario. This report provides top line data relating to the clinical trials on Scabies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 8 Top Countries Contributing to Clinical Trials in Europe 9 Top Countries Contributing to Clinical Trials in North America 10 Top Countries Contributing to Clinical Trials in Middle East and Africa 11 Top Countries Contributing to Clinical Trials in Central and South America 12 Clinical Trials by G7 Countries: Proportion of Scabies to Dermatology Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Scabies to Dermatology Clinical Trials 16 Clinical Trials by Phase 17 In Progress Trials by Phase 18 Clinical Trials by Trial Status 19 Clinical Trials by End Point Status 20 Subjects Recruited Over a Period of Time 21 Clinical Trials by Sponsor Type 22 Prominent Sponsors 23 Top Companies Participating in Scabies Therapeutics Clinical Trials 24 Prominent Drugs 26 Clinical Trial Profile Snapshots 27 Appendix 40 Abbreviations 40 Definitions 40 Research Methodology 41 Secondary Research 41 About GlobalData 42 Contact Us 42 Disclaimer 42 Source 43
List of Tables
Scabies Therapeutics, Global, Clinical Trials by Region, 2016* 5 Scabies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Scabies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Scabies Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8 Scabies Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9 Scabies Therapeutics Clinical Trials, North America, Top Countries, 2016* 10 Scabies Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11 Scabies Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12 Proportion of Scabies to Dermatology Clinical Trials, G7 Countries (%), 2016* 13 Scabies Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Scabies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Scabies to Dermatology Clinical Trials, E7 Countries (%), 2016* 16 Scabies Therapeutics, Global, Clinical Trials by Phase, 2016* 17 Scabies Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18 Scabies Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Scabies Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Scabies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Scabies Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22 Scabies Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Scabies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25 Scabies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26


List of Figures
Scabies Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Scabies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Scabies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Scabies Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8 Scabies Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9 Scabies Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 11 Proportion of Scabies to Dermatology Clinical Trials, G7 Countries (%), 2016* 13 Scabies Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Scabies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Scabies to Dermatology Clinical Trials, E7 Countries (%), 2016* 16 Scabies Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17 Scabies Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18 Scabies Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Scabies Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Scabies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Scabies Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22 Scabies Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Scabies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24 Scabies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26 GlobalData Methodology 41

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify